Latest filing published 20 Apr 2007 for VANTAGEMED CORP, €8,974.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven E. Curd: trading record in brief
Steven E. Curd discloses dealings in Vantagemed Corp to SEC (Form 4). In total, 5 filings cover trades dated from 14 June 2006 to 18 April 2007.
On the market, this insider has only ever bought: 1 purchase, €7,914 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises.
The record was last updated on 23 April 2007 with a transaction (€158k) in Vantagemed Corp. The clock since the last published purchase (23 June 2006) now reads 7,444 days. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven E. Curd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,230 shares@ US$0.55vantagemed common stockSEC:0001179110-07-008138:0
- 286,395 shares@ US$0.75vantagemed common stockSEC:0001179110-07-008138:1
- 22,230 shares@ US$0.45common stockSEC:0001179110-06-013991:0Canonical exit: 12 Sept 2006 (T+90)
3 of 3 declarations